GBA Presents: RADIO SAVANT-!

Unfortunately we don't have this name anymore-

AMLX Amylyx Pharmaceuticals, Inc.

$31.170.51 (+1.66%)4:00 PM 03/13/23

NASDAQ | $USD | Post-Market: $37.00 +5.83 (+18.70%) 6:16 PM
 
stonedinvestor said:
THOUGHTS FROM THE OPTION KING-

GTLB-

MARCH 17->45.00's
$2.97
-0.23
-7.19%<------ Slight Discount
2.85 Bid
More...
:D:rolleyes:

Well I guess The Option King will need an obituary too, as he takes his place next to The Lizard King in the the great beyond.

GTLB---> $30.40 -$14.20
(-32%)!!!

These options you that recommended to my loyal readers here... will be worth a nickel on the ask come tomorrow. The bid column will be totally blank.

>>>You just lost 100% for the readers. :mad::mad::mad:
 
stonedinvestor said:
Unfortunately we don't have this name anymore-

AMLX Amylyx Pharmaceuticals, Inc.

$31.170.51 (+1.66%)4:00 PM 03/13/23

NASDAQ | $USD | Post-Market: $37.00 +5.83 (+18.70%) 6:16 PM
More...

$17 to $37 now
I might be @thereal-bio-king now.

vanzandt said:
WHERE IS STONEY?!:mad:

It's no fun to gloat w/o Stoney to gloat at.

Bull market or bear market....
VZ does it again.
>>>>Keeping GBA afloat in times of turmoil.

$17--->$32
:wtf::p:cool:

Amylyx Pharmaceuticals’ ALS Drug Wins FDA Approval. Shares soar.
150x-1.jpg

By
Fiona Rutherford

September 29, 2022, 9:11 PM UTC

Amylyx Pharmaceuticals Inc. won regulatory approval for its controversial treatment for amyotrophic lateral sclerosis, making it the third major medicine authorized in the US to slow the disease.

The treatment, to be called Relvyrio in the US, was approved despite uncertainty about its level of effectiveness in a clinical trial, the Food and Drug Administration said Thursday in a statement, but “given the serious and life-threatening nature of ALS and the substantial unmet need, this level of uncertainty is acceptable in this instance,” the agency said. The shares rose as much as 14% in trading after US markets closed.
More...
 
STONEY!!!!

Quit hiding.
It's ok bro, we can put your 100% loss on Gitlab behind us; no one listened anyway since I didn't endorse it.
Where's your prediction for the CPI?
Does the new Stoney Rally start today?
8th times a charm. :cool:
 
stonedinvestor said:

FND Floor & Decor Holdings, Inc.

$89.66 +2.91(+3.35%)<-------------:thumbsup:
More...
These stores, they are absolutely beautiful inside. Huge too. Lots and and lots of sqf.
But I wonder what the revenue/sqf breaks down to compared to other retailers.
Channel checks say they're not real busy.

200 Day is at $78.
It'll see that easily.
It's just 'festering' up here at $89

This is not a good stock to buy and hold Stoney.
 
GOOD MORNING... ! papa slept through the economic number i think it was 6% not 5.9% //

Amylyx price target raised to $54 from $51 at Citi 06:46 AMLX Citi raised the
Probably a nice gummy set up here // buy on retrace this am.

Little frustrated, bios that are absolutely flat for a long time I tend to punt. If one sells off, often I buy more.. the logic is not there--

Amylyx Pharmaceuticals, Inc. (AMLX)
NasdaqGS - NasdaqGS Real Time Price.
31.17+0.51(+1.66%)
At close: 04:00PM EDT
36.99+5.82(+18.67%)<------------------ wait for $34 range))))))))
Pre-Market:08:49AM EDT
 
It's interesting that DAL didn't bounce back to $39-$40 range.
Everyone loves the stock, and yet it's down here $36... it should be up way more than $0.27 pre-market if we were gonna rally today.

I dunno Stoney... I wouldn't be holding your breath for that 4200.
Sell the RIP. :sneaky:
 
--Bowlero to acquire Paradise Lanes Entertainment Center in Washington State 08:37 BOWL

--California ruling a 'big win' for Uber, Lyft and DoorDash, says Jefferies » 07:58 UBER, DASH, LYFT

Upgrade Of the Day- BVH

Bluegreen Vacations price target raised to $51 from $45 at Truist 07:49 BVH

BVH lost 19% yesterday? Why? Stk is $25!
 
You must log in or register to reply here.
Back
Top